Multidimensional assessment, which was previously
shown to yield more information about
symptom-related impact on quality of life than
unidimensional scaling (e.g., using severity
alone),
2
was retained in the MSAS (7–12).
Symptoms were recorded as present or absent,
and if present, were rated using 3- or 4-point
scales for frequency, severity, and associated
distress.